Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
about
Organic-inorganic composites for bone drug delivery.(18)F-FDG microPET imaging differentiates between septic and aseptic wound healing after orthopedic implant placement: a longitudinal study of an implant osteomyelitis in the rabbit tibia.(68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infectionsA resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect modelA comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia.Biomaterials approaches to treating implant-associated osteomyelitis.Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitisAn in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.Antibacterial effect of 317L stainless steel contained copper in prevention of implant-related infection in vitro and in vivo.Insights on the properties of levofloxacin-adsorbed Sr- and Mg-doped calcium phosphate powders.Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles.Polymer-controlled release of tobramycin from bone graft void filler.Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model.A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm.Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.Bioactive composites fabricated by freezing-thawing method for bone regeneration applicationsScaffolds as Structural Tools for Bone-Targeted Drug Delivery
P2860
Q33563523-0B4D9673-8D19-4C1C-A84A-48CE8C553EE8Q33775018-DD84CA50-956E-47ED-A7AC-ACE69E09B627Q34699288-72604504-997C-440C-9F4D-6AC8024ED943Q35225221-A897C8AD-B59A-426B-8215-D6E7F67C9E8DQ36150256-95BED22E-1988-435D-8B75-05917A8D9B76Q36555710-0AC642E4-8D44-483C-B9C2-3E953A1DC399Q36597452-15440D4F-625D-46DB-92DD-D5BA124D65E5Q37111778-371582EC-95AF-45A5-B517-59B0D60F7EC9Q39484136-222B0E87-2154-4EAA-87A4-FDD4FB57BCB3Q39684601-6C6B60A1-37B7-4AF2-B9DB-486C6F9B6AD4Q39816004-0EA2CFC7-CD6B-4130-8CEB-26F54C1252F0Q41125275-4452A306-B2D3-420C-9CCE-0B0BCBEAE9B5Q41197707-241C0388-6254-4FB7-BEC8-54FE4399024EQ41586328-C4155158-0B2E-476D-82DA-94E09FD3BF8AQ41688660-35043D5B-26A3-41B3-BF17-AA83FC1F20EDQ45173405-6B8244C3-B47E-457B-A710-5D509EE67714Q46592560-EAE170A5-96FB-4003-AA8B-D5BB0878A178Q57345079-3888AA94-6B0F-4381-927A-6ED6B0D4208AQ58794823-719826CF-BF1E-4BC9-88F5-3E4528BE2A12
P2860
Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.
@ast
Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.
@en
type
label
Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.
@ast
Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.
@en
prefLabel
Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.
@ast
Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.
@en
P2093
P2860
P1476
Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.
@en
P2093
Esa Suokas
Jari Jalava
Jyri K Koort
Minna Veiranto
Pertti Törmälä
Tatu J Mäkinen
P2860
P304
P356
10.1128/AAC.49.4.1502-1508.2005
P407
P577
2005-04-01T00:00:00Z